OGEN

Oragenics Inc

$0.60

-0.02 (-2.74%)
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...

Analyst Overview

Target Price:
Date: 13.04.2026
$2.00
(+231.67%)
Strong Buy: 0
Buy: 0
Hold: 0
Sell: 0
Strong Sell: 0
Description:
Oragenics, Inc. develops antibiotics for infectious diseases in the United States. The company is headquartered in Tampa, Florida.
Exchange:
NYSE MKT
Country:
USA
Sector:
HEALTHCARE
Industry:
BIOTECHNOLOGY
Address:
9015 TOWN CENTER PARKWAY, LAKEWOOD RANCH, FL, UNITED STATES, 34202
Fiscal year end:
December
Market capitalization:
$2.61 Million
EBITDA:
-$10.5 Million
PERatio:
0.0
EPS:
-4.56
Dividend per share:
$0.00
Dividend yield:
0.0%
Beta:
1.205

Dividends for 10 years

Loading...

Income Statements for 10 years

Loading...
Loading...

Income count if spend 1000$ ten years ago on shares

How much was you spent on shares:
$1,000
How much will you earn in 10 years:
-100%
How much will you get:
$0
Prices dates:
31-03-2016: $16,200.00 and 31-03-2026: $0.56